Correlation Between Collegium Pharmaceutical and Alkermes Plc

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Collegium Pharmaceutical and Alkermes Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Collegium Pharmaceutical and Alkermes Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Collegium Pharmaceutical and Alkermes Plc, you can compare the effects of market volatilities on Collegium Pharmaceutical and Alkermes Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Collegium Pharmaceutical with a short position of Alkermes Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Collegium Pharmaceutical and Alkermes Plc.

Diversification Opportunities for Collegium Pharmaceutical and Alkermes Plc

-0.34
  Correlation Coefficient

Very good diversification

The 3 months correlation between Collegium and Alkermes is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Collegium Pharmaceutical and Alkermes Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alkermes Plc and Collegium Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Collegium Pharmaceutical are associated (or correlated) with Alkermes Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alkermes Plc has no effect on the direction of Collegium Pharmaceutical i.e., Collegium Pharmaceutical and Alkermes Plc go up and down completely randomly.

Pair Corralation between Collegium Pharmaceutical and Alkermes Plc

Given the investment horizon of 90 days Collegium Pharmaceutical is expected to generate 3.05 times more return on investment than Alkermes Plc. However, Collegium Pharmaceutical is 3.05 times more volatile than Alkermes Plc. It trades about 0.14 of its potential returns per unit of risk. Alkermes Plc is currently generating about -0.06 per unit of risk. If you would invest  3,044  in Collegium Pharmaceutical on October 20, 2024 and sell it today you would earn a total of  291.00  from holding Collegium Pharmaceutical or generate 9.56% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Collegium Pharmaceutical  vs.  Alkermes Plc

 Performance 
       Timeline  
Collegium Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Collegium Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's essential indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
Alkermes Plc 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Alkermes Plc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent forward-looking signals, Alkermes Plc may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Collegium Pharmaceutical and Alkermes Plc Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Collegium Pharmaceutical and Alkermes Plc

The main advantage of trading using opposite Collegium Pharmaceutical and Alkermes Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Collegium Pharmaceutical position performs unexpectedly, Alkermes Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alkermes Plc will offset losses from the drop in Alkermes Plc's long position.
The idea behind Collegium Pharmaceutical and Alkermes Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Complementary Tools

Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon